184 related articles for article (PubMed ID: 34620946)
1. Irbesartan, an angiotensin II type 1 receptor blocker, inhibits colitis-associated tumourigenesis by blocking the MCP-1/CCR2 pathway.
Hachiya K; Masuya M; Kuroda N; Yoneda M; Tsuboi J; Nagaharu K; Nishimura K; Shiotani T; Ohishi K; Tawara I; Katayama N
Sci Rep; 2021 Oct; 11(1):19943. PubMed ID: 34620946
[TBL] [Abstract][Full Text] [Related]
2. Monocytes infiltrate the pancreas via the MCP-1/CCR2 pathway and differentiate into stellate cells.
Ino K; Masuya M; Tawara I; Miyata E; Oda K; Nakamori Y; Suzuki K; Ohishi K; Katayama N
PLoS One; 2014; 9(1):e84889. PubMed ID: 24416305
[TBL] [Abstract][Full Text] [Related]
3. Irbesartan attenuates ischemic brain damage by inhibition of MCP-1/CCR2 signaling pathway beyond AT₁ receptor blockade.
Tsukuda K; Mogi M; Iwanami J; Min LJ; Jing F; Oshima K; Horiuchi M
Biochem Biophys Res Commun; 2011 Jun; 409(2):275-9. PubMed ID: 21575596
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of MCP-1/CCR2 signaling pathway is involved in synergistic inhibitory effects of irbesartan with rosuvastatin on vascular remodeling.
Ohshima K; Mogi M; Nakaoka H; Jing F; Iwanami J; Min LJ; Tsukuda K; Kanno H; Ogimoto A; Higaki J; Horiuchi M
J Am Soc Hypertens; 2012; 6(6):375-84. PubMed ID: 23107893
[TBL] [Abstract][Full Text] [Related]
5. Infiltrating CCR2
Kuroda N; Masuya M; Tawara I; Tsuboi J; Yoneda M; Nishikawa K; Kageyama Y; Hachiya K; Ohishi K; Miwa H; Yamada R; Hamada Y; Tanaka K; Kato T; Takei Y; Katayama N
Sci Rep; 2019 Jun; 9(1):8568. PubMed ID: 31189971
[TBL] [Abstract][Full Text] [Related]
6. Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis.
Urushihara M; Ohashi N; Miyata K; Satou R; Acres OW; Kobori H
Hypertension; 2011 Mar; 57(3):586-93. PubMed ID: 21282555
[TBL] [Abstract][Full Text] [Related]
7. Aortic adventitial fibroblasts participate in angiotensin-induced vascular wall inflammation and remodeling.
Tieu BC; Ju X; Lee C; Sun H; Lejeune W; Recinos A; Brasier AR; Tilton RG
J Vasc Res; 2011; 48(3):261-72. PubMed ID: 21099231
[TBL] [Abstract][Full Text] [Related]
8. Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling.
Ishibashi M; Hiasa K; Zhao Q; Inoue S; Ohtani K; Kitamoto S; Tsuchihashi M; Sugaya T; Charo IF; Kura S; Tsuzuki T; Ishibashi T; Takeshita A; Egashira K
Circ Res; 2004 May; 94(9):1203-10. PubMed ID: 15059935
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin receptor blocker irbesartan reduces stress-induced intestinal inflammation via AT1a signaling and ACE2-dependent mechanism in mice.
Yisireyili M; Uchida Y; Yamamoto K; Nakayama T; Cheng XW; Matsushita T; Nakamura S; Murohara T; Takeshita K
Brain Behav Immun; 2018 Mar; 69():167-179. PubMed ID: 29155324
[TBL] [Abstract][Full Text] [Related]
10. CD30L is involved in the regulation of the inflammatory response through inducing homing and differentiation of monocytes via CCL2/CCR2 axis and NF-κB pathway in mice with colitis.
Mei C; Meng F; Wang X; Yan S; Zheng Q; Zhang X; Fu W; Xue J; Wang S; He Y; Sun X; Jiang X; Wang Y
Int Immunopharmacol; 2022 Sep; 110():108934. PubMed ID: 35834956
[TBL] [Abstract][Full Text] [Related]
11. Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice.
Popivanova BK; Kostadinova FI; Furuichi K; Shamekh MM; Kondo T; Wada T; Egashira K; Mukaida N
Cancer Res; 2009 Oct; 69(19):7884-92. PubMed ID: 19773434
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin AT1 receptor antagonist irbesartan decreases lesion size, chemokine expression, and macrophage accumulation in apolipoprotein E-deficient mice.
Dol F; Martin G; Staels B; Mares AM; Cazaubon C; Nisato D; Bidouard JP; Janiak P; Schaeffer P; Herbert JM
J Cardiovasc Pharmacol; 2001 Sep; 38(3):395-405. PubMed ID: 11486244
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II receptor blocker ameliorates stress-induced adipose tissue inflammation and insulin resistance.
Hayashi M; Takeshita K; Uchida Y; Yamamoto K; Kikuchi R; Nakayama T; Nomura E; Cheng XW; Matsushita T; Nakamura S; Murohara T
PLoS One; 2014; 9(12):e116163. PubMed ID: 25551221
[TBL] [Abstract][Full Text] [Related]
14. A small difference in the molecular structure of angiotensin II receptor blockers induces AT₁ receptor-dependent and -independent beneficial effects.
Fujino M; Miura S; Kiya Y; Tominaga Y; Matsuo Y; Karnik SS; Saku K
Hypertens Res; 2010 Oct; 33(10):1044-52. PubMed ID: 20668453
[TBL] [Abstract][Full Text] [Related]
15. NF-κB1, NF-κB2 and c-Rel differentially regulate susceptibility to colitis-associated adenoma development in C57BL/6 mice.
Burkitt MD; Hanedi AF; Duckworth CA; Williams JM; Tang JM; O'Reilly LA; Putoczki TL; Gerondakis S; Dimaline R; Caamano JH; Pritchard DM
J Pathol; 2015 Jul; 236(3):326-36. PubMed ID: 25727407
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
17. IL-6 deficiency promotes colitis by recruiting Ly6C
Cao Q; Lin Y; Yue C; Wang Y; Quan F; Cui X; Bi R; Tang X; Yang Y; Wang C; Li X; Gao X
Eur J Pharmacol; 2021 Aug; 904():174165. PubMed ID: 33979652
[TBL] [Abstract][Full Text] [Related]
18. The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis.
Tokuyama H; Ueha S; Kurachi M; Matsushima K; Moriyasu F; Blumberg RS; Kakimi K
Int Immunol; 2005 Aug; 17(8):1023-34. PubMed ID: 16000328
[TBL] [Abstract][Full Text] [Related]
19. Geniposide prevents tumor growth by inhibiting colonic interleukin-1β and monocyte chemoattractant protein-1 via down-regulated expression of cyclooxygenase-2 and thymocyte selection-associated high mobility box proteins TOX/TOX2 in azoxymethane/dextran sulfate sodium-treated mice.
Kimura Y; Sumiyoshi M; Taniguchi M
Int Immunopharmacol; 2023 May; 118():110077. PubMed ID: 37011499
[TBL] [Abstract][Full Text] [Related]
20. Lesion progression in apoE-deficient mice: implication of chemokines and effect of the AT1 angiotensin II receptor antagonist irbesartan.
Martin G; Dol F; Marés AM; Berezowski V; Staels B; Hum DW; Schaeffer P; Herbert JM
J Cardiovasc Pharmacol; 2004 Feb; 43(2):191-9. PubMed ID: 14716205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
